Lead Product(s) : Iodine,Inapplicable
Therapeutic Area : Nutrition and Weight Loss
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : IoNovo for Kids pure iodine oral spray has been granted a registration number and received regulatory approval by Turkey’s Ministry of Health as a dietary supplement determined to be safe, effective, of high quality, and eligible for sale in Turkey.
Product Name : IoNovo
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
September 13, 2023
Lead Product(s) : Iodine,Inapplicable
Therapeutic Area : Nutrition and Weight Loss
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Iodine,Inapplicable
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Approved FDF
Sponsor : Novo Integrated Sciences
Deal Size : Undisclosed
Deal Type : Acquisition
Details : Novo has acquired the intellectual property for iodine in an aqueous form that can be safely ingested and has been proven to kill viruses, bacteria and protozoa when sprayed onto your mucous membranes, the entry points for various airborne viruses.
Product Name : Iodine
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
November 30, 2021
Lead Product(s) : Iodine,Inapplicable
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Approved FDF
Sponsor : Novo Integrated Sciences
Deal Size : Undisclosed
Deal Type : Acquisition
Lead Product(s) : Vitamins [B1, B2, B3, B5, B6, B11, B12, C, D, E],Beta Carotene,Iodine,Copper,Selenium,Iron,Zinc,Chromium,Manganese,Eicosapentaenic Acid,Docosahexaenic Acid
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : Atrium Innovations
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
July 15, 2015
Lead Product(s) : Vitamins [B1, B2, B3, B5, B6, B11, B12, C, D, E],Beta Carotene,Iodine,Copper,Selenium,Iron,Zinc,Chromium,Manganese,Eicosapentaenic Acid,Docosahexaenic Acid
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : Atrium Innovations
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Iodine,Inapplicable
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase IV
Sponsor : Bayer AG
Deal Size : Inapplicable
Deal Type : Inapplicable
Contrast Enhancement on Coronary Computed Tomographic Angiography
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
June 03, 2015
Lead Product(s) : Iodine,Inapplicable
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase IV
Sponsor : Bayer AG
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Chlorhexidine Gluconate,Isopropyl Alcohol,Iodine
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : 3M Company
Deal Size : Inapplicable
Deal Type : Inapplicable
Efficacy Comparison of Two Preoperative Skin Antisepsis Preparations in Colorectal Surgery
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
November 02, 2010
Lead Product(s) : Chlorhexidine Gluconate,Isopropyl Alcohol,Iodine
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : 3M Company
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
